Investing.com - Bausch Health (NYSE: BHC) reported second quarter EPS of $1.04, $0.16 better than the analyst estimate of $0.88. Revenue for the quarter came in at $2.4B versus the consensus estimate of $2.34B.
Bausch Health's stock price closed at $6.03. It is down -22.89% in the last 3 months and down -33.76% in the last 12 months.
Bausch Health saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Bausch Health's stock price’s past reactions to earnings here.
According to InvestingPro, Bausch Health's Financial Health score is "good performance".
Check out Bausch Health's recent earnings performance, and Bausch Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar